Preclinical Evaluation of CD40-Directed Immunotherapy in B-Cell Lymphoma Using [<sup>18</sup>F]Fluorothymidine-PET
Advances in Molecular Imaging · 2015
DOI: 10.4236/ami.2015.52002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Molecular Imaging, 2015. Verfasst von Nicolas Graf und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Graf, N., Li, Z., Herrmann, K., Aichler, M., Slawska, J., Walch, A., Peschel, C., Schwaiger, M., Buck, A. K., Dechow, T., & Keller, U. (2015). Preclinical Evaluation of CD40-Directed Immunotherapy in B-Cell Lymphoma Using [18F]Fluorothymidine-PET. Advances in Molecular Imaging. https://doi.org/10.4236/ami.2015.52002
Vancouver
Graf N, Li Z, Herrmann K, Aichler M, Slawska J, Walch A, et al. Preclinical Evaluation of CD40-Directed Immunotherapy in B-Cell Lymphoma Using [18F]Fluorothymidine-PET. Advances in Molecular Imaging. 2015. doi:10.4236/ami.2015.52002
BibTeX
@article{Graf2015,
author = {Graf, Nicolas and Li, Zhoulei and Herrmann, Ken and Aichler, Michaela and Slawska, Jolanta and Walch, Axel and Peschel, Christian and Schwaiger, Markus and Buck, Andreas K. and Dechow, Tobias and Keller, Ulrich},
title = {Preclinical Evaluation of CD40-Directed Immunotherapy in B-Cell Lymphoma Using [18F]Fluorothymidine-PET},
journal = {Advances in Molecular Imaging},
year = {2015},
doi = {10.4236/ami.2015.52002}
}
EUVIMED